NLS Pharmaceutics Ltd. -CW25NLSPWPreferred / convertible
13F holders, Q4 2024 (December 31)5holders
1new positions
1sold out
1famous investor
$0.01avg. 13F price*
At the end of Q4 2024, 5 institutions reported holding NLS Pharmaceutics Ltd. -CW25 (NLSPW) in their 13F filings, unchanged from Q3 2024. 1 opened new positions and 1 sold out. The largest holders were Wolverine Asset Management LLC ($3K), Hudson Bay Capital Management LP ($821) and Clear Street LLC ($753). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- NLS Pharmaceutics Ltd. -CW25
- CUSIP
- H57830111
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $3K |
| Exits | 1 | $2K |
All 13F filers, Q3 2024 → Q4 2024: 294,700 shares bought and 200,668 shares sold, net +94,032 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Wolverine Asset Management LLC | — | New | 245,000 | $3K |
| Hudson Bay Capital Management LP | — | No change | 71,356 | $821 |
| Clear Street LLC | — | Add +603.0% | 57,942 | $753 |
| Citadel Advisors | — | Reduce -3.4% | 18,958 | $246 |
| Armistice Capital, LLC | — | No change | 12,500 | $163 |
"% of holder's portfolio" is NLSPW's weight in each manager's 13F, not the share of NLS Pharmaceutics Ltd. -CW25 the manager owns.